A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

被引：0
|
作者：
Sun Jin Sym
Dae Ho Lee
Hye Jin Kang
Seung Hyun Nam
Ho Young Kim
Seok Jin Kim
Hyeon Seok Eom
Won Seog Kim
Cheolwon Suh
机构：
[1] Asan Medical Center,Department of Internal Medicine
[2] University of Ulsan College of Medicine,Department of Medicine
[3] Korea Institute of Radiological and Medical Sciences,Department of Internal Medicine
[4] Seoul Veterans Hospital,Department of Internal Medicine, Sacred Heart Hospital
[5] College of Medicine,Department of Internal Medicine
[6] Hallym University,Hematology–Oncology Clinic, Research Institute and Hospital
[7] College of Medicine,Department of Medicine, Samsung Medical Center
[8] Korea University,Department of Internal Medicine
[9] National Cancer Center,undefined
[10] School of Medicine,undefined
[11] Sungkyunkwan University,undefined
[12] Gachon University Gil Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Oxaliplatin; Lymphoma; Salvage therapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 33
页数：6
相关论文
共 50 条
  • [41] Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia:: a phase II multicenter trial
    Wiseman, GA
    Gordon, LI
    Multani, PS
    Witzig, TE
    Spies, S
    Bartlett, NL
    Schilder, RJ
    Murray, JL
    Saleh, M
    Allen, RS
    Grillo-López, AJ
    White, CA
    BLOOD, 2002, 99 (12) : 4336 - 4342
  • [42] Activity of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymphoma.
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Fayad, L
    Romaguera, J
    BLOOD, 2002, 100 (11) : 296B - 296B
  • [43] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [44] A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma
    Lim, Soon-Thye
    Fayad, L.
    Tulpule, A.
    Modiano, M.
    Cabanillas, F.
    Laffranchi, B.
    Allievi, C.
    Bernareggi, A.
    Levine, Alexandra M.
    LEUKEMIA & LYMPHOMA, 2007, 48 (02) : 374 - 380
  • [45] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Aggressive non-Hodgkin's lymphoma - Economics of high-dose therapy
    Beard, SM
    Wall, L
    Gaffney, L
    Sampson, F
    PHARMACOECONOMICS, 2004, 22 (04) : 207 - 224
  • [47] Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
    Oki, Y
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Bleyer, A
    Loyer, E
    Younes, A
    CANCER, 2005, 104 (04) : 781 - 787
  • [48] High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result
    Michot, Jean-Marie
    Annereau, Maxime
    Danu, Alina
    Legoupil, Clemence
    Bertin, Louis
    Chahine, Claude
    Achab, Nadia
    Antosikova, Anna
    Cerutti, Ariane
    Rossignol, Julien
    Ghez, David
    Willekens, Christophe
    Dartigues, Peggy
    Lazarovici, Julien
    Lemare, Francois
    Ribrag, Vincent
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 281 - 290
  • [49] Phase II study of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymhoma (NHL)
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, F
    Bleyer, A
    BLOOD, 2003, 102 (11) : 639A - 640A
  • [50] High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplantation (ASCT) in patients with primary refractory aggressive Non-Hodgkin's lymphoma
    Rodriguez, J
    Caballero, MD
    Solano, C
    Lahuerta, JJ
    Arranz, R
    Sureda, A
    Zuazu, J
    Marin, J
    García-Laraña, J
    López-Guillermo, A
    SanMiguel, J
    Conde, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S260 - S261
12345